참고문헌 (38)

1. Proc. Natl. Acad. Sci. USA R. J. Arceci 85 4350 1988 10.1073/pnas.85.12.4350 Arceci, R. J., Croop, J. M., Horwitz, S. B. and Housman, D., The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus.Proc. Natl. Acad. Sci. USA, 85, 4350-4354 (1988). 

   상세보기

2. Arch. Pharm. Res. N. I. Baek 18 164 1995 10.1007/BF02979189 Baek, N. I., Kim, D. S., Lee, Y. H., Park, J. D., Lee, C. B. and Kim, S. I., Cytotoxicities of ginseng saponins and their degradation products against some cancer cell lines.Arch. Pharm. Res., 18, 164-168 (1995). 

   원문보기 상세보기

3. Biochem. Pharmacol. W. T. Beck 36 2879 1987 10.1016/0006-2952(87)90198-5 Beck, W. T., The cell biology of multidrug resistance.Biochem. Pharmacol., 36, 2879-2887 (1987). 

   상세보기

4. Bull. Cancer W. T. Beck 77 1131 1990 Beck, W. T., Strategies to circumvent multidrug resistance due to P-glycoprotein or to altered DNA topoisomerase II.Bull. Cancer, 77, 1131-1141 (1990). 

   상세보기

5. Cancer Res. H.-X. Chen 53 1974 1993 Chen, H.-X., Bamberger, U., Heckel, A., Guo, X. and Cheng, Y.-C., BIBW22, a dipyridamole analog, acts as a bifunctional modulator on tumor cells by influncing both p-glycoprotein.Cancer Res., 53, 1974-1977 (1993). 

   상세보기

6. Can. J. Physiol. Pharmacol. S. P. C. Cole 70 313 1992 10.1139/y92-040 Cole, S. P. C., The 1991 Merck Frost Award. Multidrug resistance in small cell lung cancer.Can. J. Physiol. Pharmacol., 70, 313-329 (1992). 

   상세보기

7. Science (Washington D.C.) S. P. Cole 260 879 1993 10.1126/science.8098549 Cole, S. P. and Deelay, R. G., Multidrug resistance-associated protein: sequence correction.Science (Washington D.C.), 260, 879 (1993). 

   상세보기

8. Br. J. Cancer S. P. C. Cole 59 42 1989 10.1038/bjc.1989.9 Cole, S. P. C., Downers, H. F. and Slovak, M. L., Effect of calcium antagonists on the chemosensitivity of two drug resistant human tumor cell lines which do not overexpress P-glycoprotein.Br. J. Cancer, 59, 42-46 (1989). 

   상세보기

9. Cancer Res. S. P. C. Cole 51 3345 1991 Cole, S. P. C., Chanda, E. R., Dicke, F. P., Gerlach, J. H. and Mirski, S. E. L., Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II.Cancer Res., 51, 3345-3352 (1991). 

   상세보기

10. Ann. Rev. Biochem. J. A. Endicott 58 137 1989 10.1146/annurev.bi.58.070189.001033 Endicott, J. A. and Ling, V., The biochemistry of p-glycoprotein-mediated multidrug resistance.Ann. Rev. Biochem., 58, 137-171 (1989). 

    상세보기

11. Cancer Res. A. Fojo 45 3002 1985 Fojo, A., Akiyama, S. I., Gottesman, M. M. and Pastan, I., Reduced drug accumulation in multiply drug resistant human KB carcinoma cell lines.Cancer Res., 45, 3002-3007 (1985). 

    상세보기

12. Pharmacol. Rev. J. M. Ford 42 155 1990 Ford, J. M. and Hait, W. N., Pharmacology of drugs that alter multidrug resistance in cancer.Pharmacol. Rev., 42, 155-199 (1990). 

    상세보기

13. Proceedings of the American Association for Cancer Research C. L. Gaj 36 346 1995 Gaj, C. L., Anyanwutaku, I. O., Coli, S. C., Chang, Y. and Cheng, Y.C., Reversal of multidrug resistance associated protein mediated multidrug resistance in a human carcinoma cell line by the V-enanciomer of verapamil. Proceedings of the American Association for Cancer Research, 36, 346 (1995). 

14. J. Biol. Chem. M. M. Gottesman 263 12163 1988 10.1016/S0021-9258(18)37730-5 Gottesman, M. M. and Pastan, I., The multidrug transporter, a double-edged sword.J. Biol. Chem., 263, 12163-12166 (1988). 

    상세보기

15. Ann. Rev. Biochem. M. M. Gottesman 62 385 1993 10.1146/annurev.bi.62.070193.002125 Gottesman, M. M. and Pastan, I., Biochemistry of multidrug resistance mediated by the multidrug transporter.Ann. Rev. Biochem., 62, 385-427 (1993). 

    상세보기

16. Anal. Biochem. J. F. Graeme 139 272 1984 10.1016/0003-2697(84)90002-2 Graeme, J. F., Bruce, C. B. and William, R. W., A semiautomated microculture method for investigating growth inhibitory effects of cytotoxic compounds on exponentially growing carcinoma cells.Anal. Biochem., 139, 272-277 (1984). 

    상세보기

17. Cancer Res. C. E. Grant 54 2 357 1994 Grant, C. E., Valdimarsson, G., Hipfner, D. R., Almquist, K. C., Cole, S. P. and Deeley, R. G., Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs.Cancer Res., 54(2), 357-366 (1994). 

    상세보기

18. Nature P. Gros 323 728 1986 10.1038/323728a0 Gros, P., Ben Neriah, Y., Croop, J. M. and Housman, D. E., Isolation and expression of a complementary DNA that confers multidrug resistance.Nature, 323, 728-731 (1986). 

    상세보기

19. J. Biol. Chem. C. E. Herzog 268 2946 1993 10.1016/S0021-9258(18)53865-5 Herzog, C. E., Tsokos, M., Bates, S. E. and Fojo, A. T., Increasedmdr1/p-glycopro-tein expression after treatment of human colon carcinoma cells with p-glycoprotein antagonists.J. Biol. Chem. 268, 2946-2952 (1993). 

    상세보기

20. Arch. Pharm. Res. K. S. Im 18 454 1995 10.1007/BF02976351 Im, K. S., Chang, E. H. and Je, N. K., A modified alkaline hydrolysis of total ginsenosides yielding genuine agycones and prosapogenols.Arch. Pharm. Res., 18, 454-457 (1995). 

    원문보기 상세보기

21. Yakhak Hoeji S. I. Kim 35 5 432 1991 Kim, S. I., Baek, N. I., Kim, D. S., Lee, Y. H., Kang, K. S. and Park, J. D., Preparation of a 20(R)-Ginsenoside Rh2 and the 20(S) epimer from protopanaxadiol saponins of Panax ginseng C. A. Meyer,Yakhak Hoeji, 35(5), 432-437 (1991a). 

    원문보기 상세보기

22. Korean J. Ginseng Sci S. I. Kim 15 3 188 1991 Kim, S. I., Park, J. D., Lee, Y. H., Nam, G. Y. and Baek, N. I., Preparation of 20(R)- and 20(S)-ginsenoside Rh1 from ginsenoside Re.Korean J. Ginseng Sci, 15(3), 188-191 (1991b). 

23. Yakhak Hoeji D. S. Kim 39 1 85 1995 Kim, D. S., Baek, N. I., Park, J. D., Lee, Y. H., Jeong, S. Y., Lee, C. B. and Kim, S. I., Preparation and structure determination of a new glycoside, (20E)-ginsenoside Rh3, and its isomer from diol-type ginseng saponin.Yakhak Hoeji, 39(1), 85-93 (1995). 

    원문보기 상세보기

24. Yakugaku Zasshi I. Kitagawa 103 612 1983 10.1248/yakushi1947.103.6_612 Kitagawa, I., Yoshikawa, M., Yoshihara, M., Hayashi, T. and Taniyama, T., Chemical studies on crude drug procession.Yakugaku Zasshi, 103, 612 (1983). 

    상세보기

25. Kitagawa, I. Chemical studies on crude drug processing-Red and White ginseng, Taejeon, Korea,4th Int’l. Ginseng Symp., pp 159-168 (1984). 

26. Cancer Res. N. Krishinamachary 53 3658 1993 Krishinamachary, N. and Center, M. S., The MRP gene associated with a non-Pglycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein.Cancer Res., 53, 3658-3661 (1993). 

    상세보기

27. J. Natl. Cancer Inst. S-L. Lai 81 1144 1989 10.1093/jnci/81.15.1144 Lai, S-L., Goldstein, L. J., Gottesman, M. M., Pastan, I., Tsai, C-M., Johnsson, B-E., Mulshine, J. L., Ihde, D. C., Kayser, K. and Gazdar, A. F., MDR1 gene expression in lung cancer.J. Natl. Cancer Inst., 81, 1144-1150 (1989). 

    상세보기

28. Cancer suppl. B. Leyland-Jones 7 11 3484 1993 10.1002/1097-0142(19931201)72:11+<3484::AID-CNCR2820721615>3.0.CO;2-L Leyland-Jones, B., Dalton, W., Fisher, G. A. and Sikik, B. I., Reversal of multidrug resistance to cancer chemotherapy.Cancer suppl., 7(11), 3484-3488 (1993). 

    상세보기

29. Cancer R. Markus 72 12 3533 1993 Markus, R. and Werner, S., Clinical trials of agents that reverse multidrug resistance.Cancer, 72(12), 3533-3563 (1993). 

30. Cancer Res. S. E. I. Mirski 47 2594 1987 Mirski, S. E. I., Gerlach, J. H. and Cole, S. P. C., Multidrug resistance in a human small cell lung cancer cell line selected in Adriamycin.Cancer Res., 47, 2594-2598 (1987). 

    상세보기

31. R. F. Ozols 1991 10.1007/978-1-4615-3872-1 Molecular and clinical advances in anticancer drug resistance Ozols, R. F.,Molecular and clinical advances in anticancer drug resistance. Kluwer Academic Publisher, Boston (1991). 

    

32. Proc. Natl. Acad. Sci. USA. I. Pastan 85 4486 1988 10.1073/pnas.85.12.4486 Pastan, I., Gottesman, M. M., Ueda, K., Lovelace, E., Rutherford, A. V. and Willingham, M. A., Retrovirus carrying andmdr1 cDNA confers multidrug resistance and polarized expression of p-glycoprotein in MDCK cells.Proc. Natl. Acad. Sci. USA., 85, 4486-4490 (1988). 

    상세보기

33. Br. J. Cancer C. W. Taylor 63 923 1991 10.1038/bjc.1991.202 Taylor, C. W., Dalton, W. S., Parrish, P. R., Gleason, M. C., Bellany, W. T., Thompson, F. H., Roe, D. J., and Trent, J. M., Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line.Br. J. Cancer, 63, 923-929 (1991). 

    상세보기

34. Cancer Bulletin L. D. Teeter 41 14 1989 Teeter, L. D., Drug resistance and chemotherapy: a perspective.Cancer Bulletin, 41, 14-20 (1989). 

35. Cancer Res. T. Tsuruo 41 1967 1981 Tsuruo, T., Iida, H., Tsukagoshi, S. and Sakurai, Y., Overcoming of vincristine resistance in P388 leukemiain vivo andin vitro through inhanced cytotoxicity of vincristine and vinblastine by verapamil.Cancer Res., 41, 1967-1972 (1981). 

    상세보기

36. Br. J. Cancer P. R. Twentyman 56 55 1987 10.1038/bjc.1987.153 Twentyman, P. R., Fox, N. E. and White, D. J. G., Cyclosporin A and its analogues as modifiers of a-driamycin and vincristine resistance in a multidrug resistant human lung cancer cell line.Br. J. Cancer, 56, 55-57 (1987). 

    상세보기

37. Proc. Natl. Acad Sci. USA. K. Ueda 84 3004 1987 10.1073/pnas.84.9.3004 Ueda, K., Cardarelli, C., Gottesman, M. M. and Pastan, I., Expression of a full-length cDNA for the humanmdr1 gene confers resistance to colchicine, doxorubicin, and vinblastine.Proc. Natl. Acad Sci. USA. 84, 3004-3008 (1987). 

    상세보기

38. J. Biol. Chem. C. P. H. Yang 265 782 1989 10.1016/S0021-9258(19)85010-X Yang, C. P. H., DePinho, S. H., Greenberger, L. M., Arceci, R. J. and Horwitz, S. B., Progesterone interacts with P-glycoprotein in multidrug-resistant clees and the endometrium of gravid uterus.J. Biol. Chem., 265, 782-788 (1989). 

    상세보기